FDA.reportPublic FDA data

Antara 130 MG Oral Capsule

RxCUI
578797
RxNorm name
Antara 130 MG Oral Capsule
Display name
Antara 130 MG Oral Capsule
Full name
Antara 130 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ANTARAFENOFIBRATELupin Pharmaceuticals, Inc.24790a18-0291-4b88-a724-acac43b616ce2025-10-01Warnings, Adverse reactionsExact identifier
rxcui: 578797

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
24790a18-0291-4b88-a724-acac43b616ceAntara 130 MG Oral Capsule [PSN] · fenofibrate 130 MG Oral Capsule [Antara] [SBD] · Antara 130 MG Oral Capsule [SY]317These highlights do not include all the information needed to use ANTARA safely and effectively. See full prescribing information for ANTARA. ANTARA (fenofibrate) capsules, for oral use Initial U.S. Approval: 199320251001
acca05ab-185b-41a6-9ce2-783fc3c3cf96Antara 130 MG Oral Capsule [PSN] · fenofibrate 130 MG Oral Capsule [Antara] [SBD] · Antara 130 MG Oral Capsule [SY]32Antara ® (fenofibrate) Capsules20080130